Skip to main content
SpringerLink
Log in

Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Viguier M, Richette P, Bachelez H, Wendling D, Aubin F. Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol 2009; 5: 421–31.

    Article  CAS  PubMed  Google Scholar 

  2. Fouache D, Goëb V, Massy-Guillemant N, et al. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. Rheumatology (Oxford) 2009; 48: 761–4.

    Article  CAS  Google Scholar 

  3. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 233–40.

    Article  CAS  PubMed  Google Scholar 

  4. Toussirot É, Houvenagel É, Goëb V, et al. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series. Joint Bone Spine 2012; 79: 457–63.

    Article  PubMed  Google Scholar 

  5. Daïen CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009; 48: 883–6.

    Article  Google Scholar 

  6. Delobeau M, Abdou A, Puzenat E, et al. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa. J Dermatolog Treat 2015; 27: 251–3.

    Article  PubMed  Google Scholar 

  7. Lo Nigro A, Ramonda R, Alaibac M, Modesti V, Punzi L. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers. Eur J Dermatol 2011; 21: 263–4.

    PubMed  Google Scholar 

  8. Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med 2012; 157: 846–55.

    Article  PubMed  Google Scholar 

  9. Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081–8.

    Article  CAS  PubMed  Google Scholar 

  10. Baeten D, Van Damme N, Van den Bosch F, et al. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha. Ann Rheum Dis 2001; 60: 750–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Investigation Centre in Biotherapy, INSERM CIC-1431, University Hospital of Besançon, Besançon, France

    Éric Toussirot

  2. FHU INCREASE, University Hospital of Besançon, Besançon, France

    Éric Toussirot

  3. Department of Rheumatology, University Hospital of Besançon, Besançon, France

    Éric Toussirot

  4. Department of Therapeutics and UPRES EA 4266: “Pathogenic agents and Inflammation”, University of Franche-Comté, Besançon, France

    Éric Toussirot

  5. Department of Dermatology, University Hospital of Besançon, Besançon, France

    Romain Charollais & François Aubin

  6. EA 3181, SFR 4234, University of Franche-Comté, Besançon, France

    François Aubin

Authors
  1. Éric Toussirot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Romain Charollais
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. François Aubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Éric Toussirot.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toussirot, É., Charollais, R. & Aubin, F. Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab. Eur J Dermatol 26, 406–408 (2016). https://doi.org/10.1684/ejd.2016.2784

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2016.2784

Search

Navigation